Ocular Therapeutix (OCUL) Net Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 49,253.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 506.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -569.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,218.00 |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -65,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65,750.00 |
| Dec 31, 2025 | -34,477.00 |
| Sep 30, 2025 | -27,465.00 |
| Jun 30, 2025 | -32,371.00 |
| Mar 31, 2025 | -44,174.00 |
| Dec 31, 2024 | -12,667.00 |
| Sep 30, 2024 | -10,818.00 |
| Jun 30, 2024 | -6,115.00 |
| Mar 31, 2024 | 8,334.00 |
| Dec 31, 2023 | 6,492.00 |
| Sep 30, 2023 | 12,536.00 |
| Jun 30, 2023 | 110,308.00 |
| Mar 31, 2023 | 51,645.00 |
| Dec 31, 2022 | 87,152.00 |
| Sep 30, 2022 | 276,110.00 |
| Jun 30, 2022 | 333,932.00 |
| Mar 31, 2022 | 398,771.00 |
| Dec 31, 2021 | 329,194.00 |
| Sep 30, 2021 | 283,978.00 |
| Jun 30, 2021 | 194,354.00 |
| Mar 31, 2021 | 375,031.00 |
| Dec 31, 2020 | 247,178.00 |
| Sep 30, 2020 | 270,999.00 |
| Jun 30, 2020 | 302,132.00 |
| Mar 31, 2020 | 267,920.00 |
| Dec 31, 2019 | 149,000.00 |
| Sep 30, 2019 | -94,227.00 |
| Jun 30, 2019 | -91,968.00 |
| Mar 31, 2019 | -152,980.00 |
| Dec 31, 2018 | -75,244.00 |
| Sep 30, 2018 | 2.51 Mn |
| Jun 30, 2018 | 5,036.00 |
| Mar 31, 2018 | -86,450.00 |
| Dec 31, 2017 | -111,530.00 |
| Sep 30, 2017 | 212,326.00 |
| Jun 30, 2017 | 232,681.00 |
| Mar 31, 2017 | 2.26 Mn |